John Androsavich, PhD, is the Senior Director of Pulmonary & Liver Biology at Translate Bio.  John previously held research positions at Regulus Therapeutics and RaNA Therapeutics, where he discovered and developed candidate drug molecules targeting non-coding RNAs. He has focused his career on the full spectrum of nucleic acid therapeutics, working on both oligo and mRNA drug discovery, over the last decade after receiving his PhD in Chemical Biology from the University of Michigan. At Translate Bio, he currently leads the biology team in efforts focused on rare genetic diseases; and is the program lead for Translate Bio’s next-generation CFTR program.